Although IL-10 is a well-validated anti-inflammatory effector in ALI/ARDS (with aerosol protein IL-10 improving outcomes in murine ALI), direct IL-10 mRNA delivery to the lung remains at the preclinical/early-stage concept level [92]. The gene discussed is IL10; the disease is acute respiratory distress syndrome.